Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Comperat

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Annals of Diagnostic Pathology|May 24, 2022
Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional studyJiri Kolar, Andrea Feu Llaurado, Monika Ulamec, et al.
Arab Journal of Urology|January 5, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancerPawel Rajwa, Fahad Quhal, David D'Andrea, et al.
Nature Reviews. Urology|November 30, 2023
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data SystemValeria Panebianco, Alberto Briganti, Thierry N Boellaard, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 5, 2025
Observer Variation in the Diagnosis of Testicular Sex Cord-Stromal Tumors by a Genitourinary Pathology Society and International Society of Urological Pathology Panel: Paving the Way for a New ClassificationDaniel M Berney, Maurizio Colecchia, Eva Comperat, et al.
Histopathology|January 29, 2014
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologistsAmanda H Seipel, Brett Delahunt, Hemamali Samaratunga, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Histopathology|June 18, 2025
Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP)Andres M Acosta, Maurizio Colecchia, Eva Comperat, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
The American Journal of Surgical Pathology|July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary BladderMichelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Annals of Diagnostic Pathology|May 24, 2022
Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional studyJiri Kolar, Andrea Feu Llaurado, Monika Ulamec, et al.
Arab Journal of Urology|January 5, 2024
Positive family history as a predictor for disease outcomes after radical prostatectomy for nonmetastatic prostate cancerPawel Rajwa, Fahad Quhal, David D'Andrea, et al.
Nature Reviews. Urology|November 30, 2023
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data SystemValeria Panebianco, Alberto Briganti, Thierry N Boellaard, et al.
Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 5, 2025
Observer Variation in the Diagnosis of Testicular Sex Cord-Stromal Tumors by a Genitourinary Pathology Society and International Society of Urological Pathology Panel: Paving the Way for a New ClassificationDaniel M Berney, Maurizio Colecchia, Eva Comperat, et al.
Histopathology|January 29, 2014
Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologistsAmanda H Seipel, Brett Delahunt, Hemamali Samaratunga, et al.
Genome Medicine|September 15, 2022
A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapyFlorian A Büttner, Stefan Winter, Viktoria Stühler, et al.
Histopathology|June 18, 2025
Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP)Andres M Acosta, Maurizio Colecchia, Eva Comperat, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisBurles A Johnson Iii, Benjamin A Teply, Catherine Kagemann, et al.
The American Journal of Surgical Pathology|July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary BladderMichelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
Pageof 17